Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Estruma ovárico maligno con foco de carcinoma papilar

Malignant struma with ovarian carcinoma papillary spotlight.

Ginecol Obstet Mex. 2018 enero;86(1):54-61.

https://doi.org/10.24245/gom.v86i1.927

Rojo-Novo S,1 Tato-Varela S,2 Pantoja-Garrido M,1 Gutiérrez-Domingo A3

1 Ginecología y Obstetricia, Hospital Virgen Macarena, Sevilla, España.
2 Departamento de Ginecología y Obstetricia, Donau Isar Klinikum en Deggendorf, Bayern, Alemania.
3 Servicio de Anatomía Patológica, Hospital Virgen Macarena, Sevilla, España.


Corrrespondencia:

Dra. Sara Rojo Novo
sararn677@hotmail.com

Debe citarse como:

Rojo-Novo S, Tato-Varela S, Pantoja-Garrido M, Gutiérrez-Domingo A. Estruma ovárico maligno con foco de carcinoma papilar. Ginecol Obstet Mex. 2018 enero;86(1):54-61. DOI: https://doi.org/10.24245/gom.v86i1.927

Resumen

ANTECEDENTES: el estruma ovárico es una variedad infrecuente de teratoma quístico.

CASO CLÍNICO: paciente de 42 años de edad en quien durante una revisión ginecológica rutinaria se evidenció, por ecografía, un quiste anexial derecho complejo, bilobulado, de 10 cm compuesto por dos formaciones heterogéneas independientes, una de aspecto uniforme ecorrefringente de 52.6 mm y otra ecorrefringencia alternante de 36.7 mm. Se categorizó como teratoma quístico, lo que se confirmó por resonancia magnética nuclear. Se efectuó anexectomía derecha laparoscópica. El estudio anatomopatológico confirmó el diagnóstico microscópico de teratoma quístico maduro, que incluía a la tiroides (menos de 50% de todo el tumor), con un carcinoma papilar de patrón folicular (estruma ovárico). La cirugía ginecológica se complementó con histerectomía total, omentectomía, lavado peritoneal e inspección de la cavidad abdominal por vía laparotómica; se descartó la neoplasia residual. El estudio endocrinológico evidenció la normalidad de la tiroides y el diagnóstico ecográfico de un nódulo; posteriormente se confirmó que se trataba de hiperplasia benigna. Los marcadores tumorales tiroideos fueron negativos y, a pesar de ello, el comité de cáncer de tiroides acordó que se efectuara la tiroidectomía total y luego se indicara tratamiento con iodo radiactivo, sin evidenciar elementos neoplásicos malignos ni ganglios linfáticos afectados.

CONCLUSIONES: debido a la baja incidencia del estruma ovárico su tratamiento comprende a la cirugía ovárica y la tiroidectomía, y al yodo radioactivo en el caso de las variedades malignas; todo esto en un contexto de controversia consecuencia de la poca experiencia acumulada. 

PALABRAS CLAVE: Estruma ovárico; teratoma quístico maduro; carcinoma folicular papilar; marcadores tumorales de tiroides; tiroidectomía total.

Abstract

BACKGROUND: Struma ovarii represents a rare form of ovarial quistic teratom that contains thiroid tissue and affects mostly women between 40 and 60 years of age. Its diagnosis is based on the definitive pathological study of the piece, due to the fact that these kind of tumors lack any specific clinic and diagnostic features.

CLINICAL CASE: 42 year old patient, in which during a routine gynecological examination a bilobed complex right adnexal cyst of 10 cm composed of two independent heterogeneous formations (a uniform appearance ecorrefringente of 52.6mm and one alternate ecorrefrigencia of 36.7 mm) is evidenced by ultrasound. It is categorized as cystic teratoma and confirmed by nuclear magnetic resonance. Adnexectomy is performed laparoscopically. The pathological study confirmed the microscopic diagnosis of mature cystic teratoma including thyroid tissue (less than 50% of the tumor) with papillary carcinoma follicular pattern: Struma Ovarii. Gynecological surgery was completed with a total hysterectomy, omentectomy, washing and inspection peritoneal abdominal cavity by laparotomy discarding residual neoplasia. Endocrinological study showed normal thyroid function and ultrasound diagnosis of a nodule: benign hyperplasia was confirmed later. Thyroid tumor markers were negative and despite this, the thyroid cancer committee agreed to perform a total thyroidectomy and a treatment with radioiodine, without evidence of malignant neoplastic elements and affected lymph nodes. 

CONCLUSIONS: Its treatment is still controversial due to its low incidence, and includes not only ovarial surgery but also thyroidectomy and radioactive iodine therapy in the event of a malignant tumor.

KEYWORDS: Struma ovarii; mature cystic teratoma; papillary carcinoma follicular; thyroid tumor markers; total thyroidectomy.

    1. Wee JY, Li X, Chern BS, Chua IS. Struma ovarii: management and follow-up of a rare ovarian tumour. Singapore Med J 2015 Jan;56 (1):35-39
    2. Luo JR, Xie CB, Li ZH. Treatment for malignant struma ovarii in the eyes of thyroid surgeons. A case report and study of chinese casees reported in the literature. Medicine (Baltimore). 2014 Nov; 93(26):e147.
    3. Tanimanidis P, Chatzistamatiou K, Nikolaidou A, Kaplanis K. Struma ovarii. A case report. Hippokratia 2014, 18 (4): 357-358.
    4. Park MJ, Kim MA, Shin MK, Min HS. Follicular proliferative lesion arising in struma ovarii. J Pathol Transl Med. 2015 May;49(3):262-6.
    5. Barrera JR, Manalo LA, Ang FL. Papillary thyroid-type carcinoma arising from struma ovarii. BMJ Case Rep. 2012 Jul 11;2012. pii: bcr0320126145.
    6. Wolff EF, Hughes M, Merino MJ, et al. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as Illustrated by a BRAF- positive follicular variant of papillary thyroid cancer. Thyroid. 2010 Sep;20(9):981-7.
    7. Monti E, Mortara L, Zupo S, et al. Papillary thyroid cancer in a struma ovarii: a report of a rare case. Hormones (Athens). 2015 Jan-Mar;14(1):154-9.
    8. Qiao PF, Gao Y, Niu GM. Struma ovarii accompanied by mature cystic teratoma of the other ovary: A case report and literature review. Oncology letters. 2015 May;9(5):2053-2055.
    9. Chengjuan J, Ruiying D, Hualei Bu, et al. Coexistence of benign struma ovarii, pseudo-Meigs’ syndrome and elevated serum CA 125: Case report and review of the literature.  Oncology Letters. 2015 Apr; 9(4): 1739–1742.
    10. Robboy SJ. Shaco- Levy R, Peng RY, et al. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol. 2009 Sep; 28(5):405-422.
    11. Ayhan A, Yanik F, Tuncer R, et al. Struma ovarii. Int J Gynaecol Obstet. 1993 Aug; 42(2):143-6.
    12. De Simone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy. Gynecol Oncol. 2003 Jun;89(3):543-8.
    13. Janszen EWM, van Doorn HC, Ewing PC, de Krijger RR, de Wilt JHW, Kam BLR and de Herder WW. Malignant Struma Ovarii: Good Response after Thyroidectomy and 131I Ablation Therapy. Clin Med Oncol, 2008; 2: 147–152.
    14. Oudoux A, Leblanc E, Beaujot J and Gauthier-Kolesnikova H. Treatment and follow-up of malignant struma ovarii: Regarding two cases. Gynecol Oncol Rep. 2016 Aug; 17: 56–59.
    15. Laberge PY, Levesque S. Short-term morbidity and long-term recurrence rate of ovarian dermoid cysts treated by laparoscopy versus laparotomy. J Obstet Gynaecol Can 2006 Sep;28(9):789-93.
    16. Ezon I, Zilbert N, Pinkney L, et al. A large struma ovarii tumor removed via laparoscopy in a 16-year-old adolescent. J Pediatr Surg. 2007 Aug;42(8):E19-22.
    17. Yoo SC, Chang KH, Lyu MO, et al. Clinical characteristics of struma ovarii. J Gynecol Oncol. 2008 Jun; 19(2):135-8.
    18. Leite I, Cunha TM, Pinto Figueiredo J and Félix A. Papillary carcinoma arising in struma ovarii versus ovarian metastasis from primary thyroid carcinoma: a case report and review of the literature. J Radiol Case Rep. 2013;7(10):24–33.
    19. Corrado G, Pomati G, Russo A, Visca P, Vincenzoni C, Patrizi L and Vizza E. Ovarian metastasis from thyroid carcinoma: a case report and literature Review. Diagn Pathol. 2014; 9:193.
    20. Shuji Hamazaki, Takeshi Okino, Choutatsu Tsukayama and Shigeru Okada. Expression of thyroid transcription factor-1 in strumal carcinoid and struma ovarii: An immunohistochemical study. Pathol Int. 2002 Jul;52(7):458-62.
    21. Tan A, Stewart CJ, Garrett KL, Rye M and Cohen PA. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii. Endocr Pathol. 2015 Dec; 26(4):296-301.
    22. Leong A, Roche PJ, Paliouras M, Rochon L, Trifiro M and Tamilia M. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma. J Clin Endocrinol Metab. 2013 Dec; 98(12):4599-605.

Comentarios